Bullish indicating open at $55-$60, IPO prices at $37
180 Life Sciences Corp. (ATNF), operating as ETHZilla, announced it holds 82,186 Ether tokens valued at approximately $349 million as of August 11, 2025. The company acquired the cryptocurrency at an average price of $3,806.71 per token.
The biotechnology company also maintains approximately $238 million in cash equivalents alongside its ETH position. The company completed a PIPE transaction last week that provided capital for the cryptocurrency purchases.
"At ETHZilla we have put over $350 million in capital to work since the PIPE transaction we completed last week, and have executed on our strategy to rapidly build a differentiated Ethereum treasury vehicle," said McAndrew Rudisill, Executive Chairman of the company.
The company plans to rebrand as ETHZilla Corporation and has partnered with Electric Capital to manage its treasury strategy. The recently purchased ETH will be staked through Electric Capital’s Ethereum network strategies to generate yield, according to the company.
180 Life Sciences has 154.032 million shares outstanding as of August 5, 2025. The company originally operated as a biotechnology firm but has expanded into gaming and entertainment alongside its new cryptocurrency treasury strategy.
The company stated it will continue operating its existing biotech assets while developing its gaming initiatives. Updates on treasury management and yield generation strategies will be provided through public releases and regulatory filings.
The information is based on a company press release statement.